BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 29310489)

  • 1. Unknown primary squamous cell carcinoma of the head and neck: retrospective analysis of 80 cases.
    Mizuta M; Kitamura M; Tateya I; Tamaki H; Tanaka S; Asato R; Shinohara S; Takebayashi S; Maetani T; Kitani Y; Kumabe Y; Kojima T; Ushiro K; Ichimaru K; Honda K; Yamada K; Omori K
    Acta Otolaryngol; 2018 Jun; 138(6):590-596. PubMed ID: 29310489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Squamous cell carcinoma of cervical lymph nodes from an unknown primary site: The impact of neck dissection.
    Lou J; Wang S; Wang K; Chen C; Zhao J; Guo L
    J Cancer Res Ther; 2015 Oct; 11 Suppl 2():C161-7. PubMed ID: 26506869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radio(chemo)therapy in the management of squamous cell carcinoma of cervical lymph nodes from an unknown primary site. A retrospective analysis.
    Fakhrian K; Thamm R; Knapp S; Molls M; Pigorsch S; Haller B; Geinitz H
    Strahlenther Onkol; 2012 Jan; 188(1):56-61. PubMed ID: 22189437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neck dissection for unknown cancer of the head and neck in the era of chemoradiation.
    Amsbaugh MJ; Yusuf M; Gaskins J; Silverman C; Potts K; Bumpous J; Redman R; Perez C; Dunlap N
    Am J Otolaryngol; 2017; 38(5):588-592. PubMed ID: 28633765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metastatic squamous cell carcinoma of the neck from an unknown primary: management options and patterns of relapse.
    Iganej S; Kagan R; Anderson P; Rao A; Tome M; Wang R; Dowlatshahi M; Cosmatos H; Morgan T
    Head Neck; 2002 Mar; 24(3):236-46. PubMed ID: 11891955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined ipsilateral treatment of cervical lymph nodes metastases from an unknown primary.
    Dequanter D; Lothaire P; Gastelblum P; Nguyen TH; Lalami Y; Awada A; Andry G
    B-ENT; 2008; 4(3):157-61. PubMed ID: 18949962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of patients with head-and-neck cancer of unknown primary origin treated with intensity-modulated radiotherapy.
    Shoushtari A; Saylor D; Kerr KL; Sheng K; Thomas C; Jameson M; Reibel J; Shonka D; Levine P; Read P
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e83-91. PubMed ID: 21377283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contemporary management of lymph node metastases from an unknown primary to the neck: II. a review of therapeutic options.
    Strojan P; Ferlito A; Langendijk JA; Corry J; Woolgar JA; Rinaldo A; Silver CE; Paleri V; Fagan JJ; Pellitteri PK; Haigentz M; Suárez C; Robbins KT; Rodrigo JP; Olsen KD; Hinni ML; Werner JA; Mondin V; Kowalski LP; Devaney KO; de Bree R; Takes RP; Wolf GT; Shaha AR; Genden EM; Barnes L
    Head Neck; 2013 Feb; 35(2):286-93. PubMed ID: 22034062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carcinoma metastatic to cervical lymph nodes from an occult primary tumor: the outcome after combined-modality therapy.
    Boscolo-Rizzo P; Gava A; Da Mosto MC
    Ann Surg Oncol; 2007 May; 14(5):1575-82. PubMed ID: 17508250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer of unknown primary: does treatment modality make a difference?
    Balaker AE; Abemayor E; Elashoff D; St John MA
    Laryngoscope; 2012 Jun; 122(6):1279-82. PubMed ID: 22538837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical nodal metastases from occult primary: undifferentiated carcinoma versus squamous cell carcinoma.
    Tong CC; Luk MY; Chow SM; Ngan KC; Lau WH
    Head Neck; 2002 Apr; 24(4):361-9. PubMed ID: 11933178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The management of metastatic squamous cell carcinoma in cervical lymph nodes from an unknown primary.
    Medini E; Medini AM; Lee CK; Gapany M; Levitt SH
    Am J Clin Oncol; 1998 Apr; 21(2):121-5. PubMed ID: 9537194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Head and neck squamous cell carcinoma of unknown primary: neck dissection and radiotherapy or definitive radiotherapy.
    Demiroz C; Vainshtein JM; Koukourakis GV; Gutfeld O; Prince ME; Bradford CR; Wolf GT; McLean S; Worden FP; Chepeha DB; Schipper MJ; McHugh JB
    Head Neck; 2014 Nov; 36(11):1589-1595. PubMed ID: 23996575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical lymph node metastases from occult squamous cell carcinoma: analysis of 82 cases.
    Boscolo-Rizzo P; Da Mosto MC; Gava A; Marchiori C
    ORL J Otorhinolaryngol Relat Spec; 2006; 68(4):189-94. PubMed ID: 16479145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postoperative radiation for squamous cell carcinoma metastatic to cervical lymph nodes from an unknown primary site: outcomes and patterns of failure.
    Colletier PJ; Garden AS; Morrison WH; Goepfert H; Geara F; Ang KK
    Head Neck; 1998 Dec; 20(8):674-81. PubMed ID: 9790287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Squamous cell carcinoma of unknown primary of the head and neck: Favorable prognostic factors comparable to those in oropharyngeal cancer.
    Zhou MJ; van Zante A; Lazar AA; Groppo ER; Garsa AA; Ryan WR; El-Sayed IH; Eisele DW; Yom SS
    Head Neck; 2018 May; 40(5):904-916. PubMed ID: 29210145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis and treatment of 39 patients with cervical lymph node metastases of squamous cell carcinoma of unknown primary origin, referred to Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, 1979-98].
    Klop WM; Balm AJ; Keus RB; Hilgers FJ; Tan IB
    Ned Tijdschr Geneeskd; 2000 Jul; 144(28):1355-60. PubMed ID: 10923158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment outcomes of unknown primary squamous cell carcinoma of the head and neck.
    Hung YH; Liu SA; Wang CC; Wang CP; Jiang RS; Wu SH
    PLoS One; 2018; 13(10):e0205365. PubMed ID: 30335795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Outcome and prognostic factors of 125 loco-regionally advanced head and neck squamous cell carcinoma treated with multi-modality treatment].
    Qian W; Zhu G; Ji Q; Guo Y; Wang Y; Wang Y
    Zhonghua Zhong Liu Za Zhi; 2014 Mar; 36(3):217-22. PubMed ID: 24785284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of stage IV glottic carcinoma: therapeutic outcomes.
    Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
    Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.